Background: Proportional assist ventilation (PAV) has been shown to maintain better patient-ventilator synchrony than pressure support ventilation (PSV); however, its clinical advantage regarding invasive ventilation of COPD patients has not been clarified. Objectives: To compare the effect of PAV and PSV on respiratory parameters of hypercapnic COPD patients with acute respiratory failure (ARF). Methods: Nine intubated hypercapnic COPD patients were placed on the PAV or PSV mode in random sequence. For each mode, four levels (L1–L4) of support were applied. At each level, blood gases, flow, tidal volume (VT), airway pressure (Paw), esophageal pressure (Pes) (n = 7), patient respiratory rate (fp), ventilator rate (fv), missing efforts (ME = fp – fv) were measured. Results: We found increases in ME with increasing levels of PSV but not with PAV. PO2 and VT increased whereas PCO2 decreased significantly with increasing levels of PSV (p < 0.05). With PAV, PCO2 decreased and VT increased significantly only at L4 whereas PO2 increased from L1 to L4. Runaways were observed at L3 and L4 of PAV. The pressure-time product (PTP) was determined for effective and missing breaths. The mean total PTP per minute (of effective plus missing breaths) was 160 ± 57 cm H2O/s·min in PSV and 194 ± 60 cm H2O/s·min in PAV. Conclusion: We conclude that in COPD patients with hypercapnic ARF, with increasing support, PSV causes the appearance of ME whereas PAV develops runaway phenomena, due to the different patient-ventilator interaction; however, these do not limit the improvement of blood gases with the application of both methods.

1.
Giannouli E, Webster K, Roberts D, Younes M: Response of ventilator-dependent patients to different levels of pressure support and proportional assist. Am J Respir Crit Care Med 1999;159:1716–1725.
2.
Appendini L, Purro A, Gudjonsdottir M, Baderna P, Patessio A, Zanaboni S, Donner C, Rossi A: Physiologic response of ventilator dependent patients with chronic obstructive pulmonary disease to proportional assist ventilation and continuous positive airway pressure. Am J Respir Crit Care Med 1999;159:1510–1517.
3.
Ranieri M, Grasso S, Mascia L, Martino S, Fiore T, Brienza A, Giuliani R: Effects of proportional assist ventilation on inspiratory muscle effort in patients with chronic obstructive pulmonary disease and acute respiratory failure. Anesthesiology 1997;86:79–91.
4.
Marantz S, Patrick W, Webster K, Roberts D, Oppenheimer L, Younes M: Response of ventilator-dependent patients to different levels of proportional assist. J Appl Physiol 1996;80:397–403.
5.
Younes M: Proportional assist ventilation; in Tobin MJ (ed): Principles and Practice of Mechanical Ventilation. New York, McGraw-Hill, 1994, pp 349–370.
6.
Kuhlen R, Rossaint R: Proportional assist ventilation. Intensive Care Med 1999;25:1021–1023.
7.
Leung P, Jubran A, Tobin J: Comparison of assisted ventilator modes on triggering, patient effort, and dyspnea. Am J Respir Crit Care Med 1997;155:1940–1948.
8.
Novalesi P, Hernandez P, Wongsa A, Laporta D, Goldberg B, Gottfied S: Proportional assist ventilation in acute respiratory failure; effects on breathing pattern and inspiratory effort. Am J Respir Crit Care Med 1996;154:1330–1338.
9.
Ranieri M, Giuliani R, Mascia L, Grasso S, Petruzzelli V, Puntillo N, Perchiazzi G, Fiore T, Brienza A: Patient-ventilator interaction during acute hypercapnia: Pressure support vs proportional assist ventilation. J Appl Physiol 1996;81:426–436.
10.
Wrigge H, Crolisch W, Zinserling J, Sydaw M, Almeling G, Burchardi H: Proportional assist versus pressure support ventilation: Effects on breathing pattern and respiratory work of patients with chronic obstructive pulmonary disease. Intensive Care Med 1999;25:790–798.
11.
Ambrosino N, Rossi A: Proportional assist ventilation (PAV): A significant advance or a futile struggle between logic and practice? Thorax 2002;57:272–276.
12.
Polese G, Vitacca M, Bianchi L, Rossi A, Ambrosino N: Nasal proportional assist ventilation unloads the inspiratory muscles of stable patients with hypercapnia due to COPD. Eur Respir J 2000;16:491–498.
13.
Vitacca M, Clini E, Pagani M, Bianchi L, Rossi A, Ambrosino N: Physiologic effects of early administered mask proportional assist ventilation in patients with chronic obstructive pulmonary disease and acute respiratory failure. Crit Care Med 2000;28:1791–1797.
14.
Wysocki M, Richard JC, Meshaka P: Noninvasive proportional assist ventilation compared with non-invasive pressure support ventilation in hypercapnic acute respiratory failure. Crit Care Med 2002;30:323–329.
15.
Du HL, Ohtsuji M, Shigeta M, Chao DC, Sasaki K, Usuda Y, Yamada Y: Expiratory asynchrony in Proportional Assist Ventilation. Am J Respir Crit Care Med 2002;165:972–977.
16.
American Thoracic Society: Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:S77–S120.
17.
Rathgeber J, Burchardi H: Concept of analgosedation during mechanical ventilation. Intensive Care 1995;8:81–84.
18.
Georgopoulos D, Roussos C: Control of breathing in mechanically ventilated patients. Eur Respir J 1996;6:2151–2160.
19.
Jubran A, Van de Graaf WB, Tobin M: Variability of patient-ventilator interaction with pressure support ventilation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 1995;152:129–136.
20.
Tobin MJ, Van de Graaff WB: Monitoring of lung mechanics and work of breathing; in Tobin MJ (ed): Principles and Practice of Mechanical Ventilation. New York, McGraw-Hill, 1994, pp 987–1003.
21.
Georgopoulos D, Mitrouska I, Bshouty Z, Webster K, Patakas D, Younes M: Respiratory response to CO2 during pressure-support ventilation in conscious normal humans. Am J Respir Crit Care Med 1997;156:146–154.
22.
Meza S, Mendez M, Ostawdki M, Younes M: Susceptibility to periodic breathing with assisted ventilation during sleep in normal subjects. J Appl Physiol 1998;85:1929–1940.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.